CDMO project implementation
at Polpharma

In this webinar, our expert will cover:

  • Implementation of a CDMO project at Polpharma API
  • Technologies, equipment and organization of our state of the art laboratories to allow smooth and fast transfer and development of complex chemistry and analytical methods
  • cGMP, FDA inspected pilot plant for scale-up campaigns to commercial supplies of small volumes API
Registration by e-mail cdmo@polpharma.com
Duration: 1 h

Claudio Salvagnini

Head of CDMO

Claudio Salvagnini has many years of experience in the fine chemicals and pharmaceutical industry in commercial, business development, marketing and M&A roles. In the Polpharma API Business Unit he is responsible for the CDMO market.

Past webinars

13 April, 2021
4.00 p.m., CET

Ability to control particle size
distribution resolves multiple
formulation challenges

In this webinar, our experts will cover:

  • Why particle size is important?
  • How to get the required particle size?
  • How is it managed at Polpharma API?

Karol Sągol

Technology Development Team Manager

Karol Sągol is Technology Development Team Manager in Technological Development Department. He defended his Master at University of Gdańsk in the field of biological chemistry. For over 12 years Karol is involved at Polpharma in many projects related to crystallization process of the active substances and is responsible for both development of polymorphic form as well as troubleshooting of production processes.

22 October, 2020
2.00 p.m., CET

Approach to Nitrosamine impurity
testing and technology improvement

In this webinar, our experts will cover:

  • EMA and FDA guidelines for pharmaceutical industry
  • Polpharma API approach for nitrosamine issue
SEE MATERIALS Duration: 30 min

Adam Hałuszczuk

Leader of Nitrosamine Risk Management Group,
R&D Department API BU

Adam Hałuszczuk is an experienced organoselenium chemist with many years of experience in organic synthesis. He is pursuing his PhD at the Gdańsk University of Technology in the field of selenium chemistry. He is involved in the development and optimization of many processes at Polpharma and is directly engaged in developing an approach to nitrosamine impurities in Polpharma API BU.

Registration for Polpharma API webinar materials

Welcome to the registration form!

Thank you for your interest in our webinars. Please complete the following spaces. After registration, you will be redirected to the materials page.